NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to control bladder cancer without surgery
Disease control Recruiting nowThis study tests two drugs, durvalumab and monalizumab, in people with a type of bladder cancer that hasn't spread into the muscle. The goal is to see if the combination can make the cancer disappear or stop it from growing. About 60 adults who have not responded to standard BCG …
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: John Sfakianos • Aim: Disease control
Last updated May 17, 2026 07:07 UTC
-
Could one surgery be enough? new trial aims to cut unnecessary procedures for bladder cancer patients
Disease control Recruiting nowThis study compares a newer, single surgery using special dye and light (PDD-TURBT) against the standard approach of two surgeries for early-stage bladder cancer. About 112 adults with non-muscle invasive bladder cancer will be randomly assigned to either the new single-surgery m…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE4 • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated May 17, 2026 07:06 UTC
-
New shot for bladder tumors shows promise in early trial
Disease control Recruiting nowThis early-stage study is testing a new drug, belzupacap sarotalocan, injected directly into bladder tumors to see if it's safe and doable for people with non-muscle-invasive bladder cancer. About 55 participants will receive the injection, sometimes with a laser, and be monitore…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 17, 2026 07:06 UTC
-
Immunotherapy may replace chemo in Bladder-Sparing cancer treatment
Disease control Recruiting nowThis study tests whether combining an immunotherapy drug (pembrolizumab) with radiation works better than standard chemotherapy plus radiation for people with a high-risk, early-stage bladder cancer that hasn't spread into the muscle. About 160 participants will receive either tr…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New DNA test may spot hidden bladder cancer before surgery
Diagnosis Recruiting nowThis study is testing whether a combination of a blood test and a urine test can detect aggressive muscle-invasive bladder cancer that standard scopes might miss. About 92 people scheduled for bladder removal surgery will provide samples before their operation. If the tests prove…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Sponsor: Fox Chase Cancer Center • Aim: Diagnosis
Last updated May 14, 2026 12:06 UTC
-
Could a prostate drug help fight bladder cancer?
Knowledge-focused Recruiting nowThis early-stage trial is studying whether bicalutamide, a drug typically used for prostate cancer, can change a protein called EGFR in bladder cancer cells. About 80 adult men with non-muscle invasive bladder cancer will either receive the drug or no study drug. The goal is to l…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated May 17, 2026 06:50 UTC